Our findings suggest that HN elicits a strong cytoprotective effect in GBM cells via the FPR2 membrane-bound receptor, facilitating tumor cell migration, angiogenesis and chemoresistance in glioma cells of heterogeneous genetic backgrounds. Here, FPR2 is linked to central nervous system cancer.